ResMed RMD Income Statement
| TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | ||
|---|---|---|---|---|---|---|
| $32.85M+1.3% | $32.44M+0.5% | $32.27M+0.5% | $32.12M+4.5% | $30.74M-1.2% | ||
| $5.99M+30.0% | $4.61M+10.5% | $4.17M+14.4% | $3.64M— | —— | ||
| -$18.55M-31.9% | -$14.07M+11.0% | -$15.81M-53.5% | -$10.3M+55.7% | -$23.24M-533% | ||
| $1.52B+2.3% | $1.49B+3.3% | $1.44B+2.7% | $1.4B+6.7% | $1.31B+5.2% | ||
| —— | —— | -$15.81M-53.5% | -$10.3M+55.7% | -$23.24M-533% | ||
| $46.9M+0.8% | $46.54M+1.6% | $45.83M+1.2% | $45.27M+1.5% | $44.61M-0.7% | ||
| $34.79M+49.3% | $23.29M+59.9% | $14.57M+254% | $4.11M+154% | -$7.56M+61.0% | ||
| —— | —— | —— | $0— | $0— | ||
| $297.27M— | —— | —— | —— | —— | ||
| $171.25M+31.3% | $130.46M+5.2% | $124.03M+36.4% | $90.96M-44.5% | $163.85M+20.3% | ||
| $64.78M-26.3% | $87.96M+5.8% | $83.13M+8.4% | $76.68M-40.6% | $128.99M-11.3% | ||
| $8.19M— | —— | —— | —— | —— | ||
| $105.39M+573% | -$22.3M+73.8% | -$85.06M-2.9% | -$82.63M-326% | -$19.38M-123% | ||
| $26.91M-22.2% | $34.6M+23.6% | $27.98M-1.8% | $28.48M+3.6% | $27.49M+13.1% | ||
| -$907.75M-14.0% | -$796.58M-16.2% | -$685.77M-13.1% | -$606.25M+27.5% | -$835.65M+18.7% | ||
| -$295.26M-9.8% | -$269.02M-5.6% | -$254.77M-27.4% | -$200.05M-77.3% | -$112.84M+1.2% | ||
| $1.89B-1.3% | $1.91B+1.7% | $1.88B+7.5% | $1.75B+6.0% | $1.65B+12.0% | ||
| —— | —— | —— | $6.28M+174% | $2.3M0.0% | ||
| $600.05M+20.0% | $500.06M+25.0% | $400.03M+33.3% | $300.03M+20.0% | $250.02M+11.1% | ||
| $340.16M+2.9% | $330.63M+3.1% | $320.74M+3.2% | $310.88M+2.3% | $303.84M+2.4% | ||
| —— | —— | $139.77M-0.2% | $140.1M+560% | $21.22M-12.7% | ||
| —— | —— | $139.77M+0.4% | $139.25M+584% | $20.37M-13.1% | ||
| —— | —— | $11.82M+9.7% | $10.78M+647% | $1.44M-57.1% | ||
| $28.55M+173% | $10.47M+44.6% | $7.24M+12.8% | $6.42M-14.2% | $7.48M-4.3% | ||
| $135.74M+10.5% | $122.89M+6.9% | $114.99M+28.0% | $89.87M+6.8% | $84.16M-0.5% | ||
| $75.35M-2.1% | $76.94M+3.6% | $74.26M-0.2% | $74.44M+3.4% | $71.98M+6.1% | ||
| —— | $10M0.0% | $10M-75.0% | $40M-88.1% | $335M-39.6% | ||
| $101.64M+2.7% | $98.97M+6.8% | $92.67M+1.1% | $91.66M+3.8% | $88.3M+4.3% | ||
| $2.11B+4.4% | $2.02B+4.0% | $1.95B+3.3% | $1.88B+5.2% | $1.79B+3.0% | ||
| $1.89B+4.0% | $1.82B+4.3% | $1.74B+3.5% | $1.69B+4.5% | $1.61B+3.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is ResMed's revenue?
- ResMed (RMD) generated $5.5B in revenue over the trailing twelve months, up 10.3% year over year.
- Is ResMed profitable?
- ResMed reported $1.5B in net income over the trailing twelve months, a 27.4% net margin.
- What are ResMed's profit margins?
- Gross margin is 61.6% and operating margin is 34.2%, with a 27.4% net margin.
- What is ResMed's earnings per share?
- ResMed's diluted EPS over the trailing twelve months is $10.37.
- Where does ResMed's income statement data come from?
- Every line is extracted from ResMed's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
